Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Boccabella (Rome, Italy), C. Macaluso (Milan, Italy), M. Kokosi (London, United Kingdom), V. Alfieri (London, United Kingdom), C. Stock (London, United Kingdom), V. Kouranos (London, United Kingdom), G. Margaritopoulos (London, United Kingdom), L. Mori (London, United Kingdom), J. Barnett (London, United Kingdom), P. Molyneaux (London, United Kingdom), P. George (London, United Kingdom), F. Chua (London, United Kingdom), T. Maher (London, United Kingdom), S. Desai (London, United Kingdom), J. Jacob (London, United Kingdom), A. Devaraj (London, United Kingdom), A. Wells (London, United Kingdom), E. Renzoni (London, United Kingdom). Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis. 2155

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hemodynamics and mortality in chronic hypersensitivity pneumonitis Source: International Congress 2017 – Rare diseases Year: 2017 Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis Source: Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018 Year: 2018 Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Predicting risk of mortality of chronic pulmonary aspergillosis Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Predictors of mortality in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016 Year: 2017 Pulmonary hypertension in hypersensitivity pneumonitis. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Factors associated with increased arterial stiffness in patients with chronic hypersensitivity pneumonitis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Eur Respir J 2014; 44: 415-424 Year: 2014 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017 Predicting short-term mortality in patients with pulmonary embolism: A simple model Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Risk factors for the decline of pulmonary function among bronchiectasis patients in Japan Source: International Congress 2019 – Bronchiectasis Year: 2019 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021